What You Should Know:
- Medallion, a provider of AI-powered provider network infrastructure, today announced it has raised $43M in new funding led by Acrew Capital, with participation from Washington Harbour Partners and returning investors including Sequoia Capital, GV, and Spark Capital. The funding brings the company’s total raised to $130M, reinforcing its mission to eliminate administrative waste and streamline healthcare operations.
- The company plans to automate thousands of
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Citizen Health Secures $30M to Pioneer AI-Powered Rare Disease Care
What You Should Know:
- San Francisco-based Citizen Health, a platform empowering patients with rare and complex conditions, secures $30M in Series A funding led by 8VC, with participation from Transformation Capital and Headline, bringing the company's total funding to $44M since its launch in late 2023.
- The new capital will accelerate the development of the company’s flagship product, a personalized AI Advocate designed to help patients navigate their health journeys.
New
Read More
Better Medicine Raises $7M to Commercialize AI-Powered Radiology Tools
What You Should Know:
- Better Medicine, an AI-powered diagnostic startup for radiology, has secured nearly €6M ($6.89M) in total funding. The company recently raised €1M ($1.1M) in a pre-seed funding round led by Soulmates Ventures, with additional participation from Specialist VC, UT Ventures, and several angel investors.
- The funding follows a €2.5M ($2.9M) grant from the European Innovation Council (EIC) and other grants, bringing its total funding to €2.25M ($2.6M) in
Read More
Isaac Health Raises $10.5M to Democratize Access to Dementia Care Amid Rising Public Health Crisis
What You Should Know:
- Isaac Health, a leading health technology company for brain health and dementia care, announced today a $10.5 million Series A led by Flare Capital Partners, with participation from new investors, Industry Ventures, and Black Opal Ventures.
- Existing investors — Meridian Street Capital, B Capital, and Primetime Partners — also doubled down, with some increasing their stake. This brings the company’s total funding to $16.3 million, enabling it to expand its
Read More
Reprieve Cardiovascular Raises $61M to Fund Pivotal Heart Failure Trial
What You Should Know:
- Reprieve Cardiovascular, a clinical-stage company secures $61M in Series B funding led by Deerfield Management and included participation from several other investors, such as Arboretum Ventures, Lightstone Ventures, and an undisclosed strategic investor.
- The funding round, which combines equity investment with a debt facility will be used to support the rapid execution of the global FASTR II pivotal clinical trial and to fund key commercial readiness
Read More
FemTech: Gameto Secures $44M to Advance Stem Cell Therapy for Infertility and Menopause
What You Should Know:
- Gameto, a clinical-stage biotechnology company focused on reproductive health secures $44M in Series C funding, bringing its total capital raised to a leading $127M.
- The funding, led by Overwater Ventures with participation from multiple investors including Insight Partners and RA Capital, will support the completion of the ongoing Phase 3 trial for its lead program, Fertilo.
Fertilo: A Paradigm Shift in IVF
Fertilo is a novel therapy designed to
Read More
Arintra Raises $21M to Expand Beyond Autonomous Medical Coding
What You Should Know:
- Arintra, a provider of GenAI-native autonomous medical coding, has announced a $21M Series A funding round led by Peak XV Partners, with participation from Endeavor Health Ventures, Y Combinator, and other strategic investors.
- The funding will be used to accelerate product development, grow the team, and establish a new headquarters in the Bay Area to meet rising demand.
Redefining Medical Coding with Revenue Assurance
Healthcare
Read More
Amalgam Rx Secures $20M to Accelerate AI-Powered Healthcare Solutions
What You Should Know:
- Amalgam Rx, a company specializing in data-driven healthcare decision-making, has announced a $20M credit investment from Catalio Capital Management.
- The $20M senior secured term loan provides Amalgam with an initial draw of $12M to support its market expansion and refinance existing corporate debt. The credit investment also gives Amalgam access to Catalio’s extensive network of life sciences leaders, including its board of advisors and over 45
Read More
SetPoint Medical Raises $140M to Support Commercialization of Rheumatoid Arthritis Therapy
What You Should Know:
- SetPoint Medical, a company focused on developing innovative therapies for chronic autoimmune diseases secures $140M in private financing. This includes the final $25M tranche of its Series C funding and a substantial $115M Series D round co-led by Elevage Medical Technologies and Ally Bridge Group.
- The funding will fuel the commercialization of the SetPoint System, a groundbreaking neuroimmune modulation therapy for adults with moderate-to-severe
Read More
The PR Blindspot That’s Costing Healthcare Startups Their Next Funding Round
In today’s investment landscape, artificial intelligence is changing the way venture capitalists conduct early-stage due diligence. And if you are a health tech founder preparing for your next raise, understanding how PR fits into that equation may be one of the most strategic decisions you can make.
Over the past decade, I have helped clients raise over $1 billion in venture capital and guided dozens of companies through successful acquisitions and exits. When it comes to PR and funding,
Read More
